Related Experiment Video
Updated: Aug 18, 2026

08:00
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease
Annals of the Rheumatic Diseases
|December 1, 1975
Abstract:
A 69-year-old woman treated for 31 months with daily oral cyclophosphamide for refractory rheumatoid disease developed acute myelomonocytic leukemia 21/2 years after stopping the drug. The possibility of a casual association between the therapy and subsequent leukaemia is supported by the growing experience with cytotoxic agents.

